Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials
W Meissner, MP Hill, F Tison, CE Gross… - Trends in pharmacological …, 2004 - cell.com
Parkinson's disease (PD) is a progressive neurodegenerative disorder. Although therapies
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials.
W Meissner, MP Hill, F Tison, CE Gross… - Trends in …, 2004 - europepmc.org
Parkinson's disease (PD) is a progressive neurodegenerative disorder. Although therapies
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials
W Meissner, MP Hill, F Tison, CE Gross… - Trends in …, 2004 - infona.pl
Parkinson's disease (PD) is a progressive neurodegenerative disorder. Although therapies
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
[引用][C] Neuroprotective strategies for Parkinson's disease: Conceptual limits of animal models and clinical trials
W MEISSNER - Trends Pharmacol Sci, 2004 - cir.nii.ac.jp
Neuroprotective strategies for Parkinson's disease : Conceptual limits of animal models and
clinical trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
clinical trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials
W Meissner, MP Hill, F Tison, CE Gross… - TRENDS in …, 2004 - cell.com
Parkinson's disease (PD) is a progressive neurodegenerative disorder. Although therapies
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials
W Meissner, MP Hill, F Tison, CE Gross… - Trends in …, 2004 - Elsevier
Parkinson's disease (PD) is a progressive neurodegenerative disorder. Although therapies
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials
W Meissner, MP Hill, F Tison… - Trends in …, 2004 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is a progressive neurodegenerative disorder. Although therapies
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
that treat the symptoms of the disease have proven efficacy, strategies that slow or stop the …
[引用][C] Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials
W MEISSNER - Trends Pharmacol Sci, 2004 - cir.nii.ac.jp
Neuroprotective strategies for Parkinson's disease : conceptual limits of animal models and
clinical trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
clinical trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …